InhaLac^® 230

MEGGLE - high quality crystalline lactose producers, designed for DPIs

MEGGLE has developed a specialty lactose grade, InhaLac^®, to help meet the challenges associated with dry powder inhalation (DPI).

Inhalation aerosols offers the potential for needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins. An industry standard in dry power inhalation formulation development, lactose monohydrate is used safely in DPI formulations. Using lactose as an excipient not only improves performance efficiency of the inhaler, but also facilitates powder handling during production. Effective performance of a dry powder inhaler largely depends on the carrier material used for the drug formulation.

With our highly controlled production process different high quality sieved and milled grades are obtained, providing an adequate range of particle sizes – making them behave as individual particles.

Retest:
24 months

Standard Packaging:
25 kg - Carton box with PE-EVOH-PE + OPP-Alu-PE-liner

Particle size distribution
[Laser diffraction]

x10: 30-60 µm
x50: 70-110 µm
x90: 110-150 µm

Typical Values

Bulk Density [g/l]: 700
Tapped Density [g/l] : 850
Hausner factor: 1.21
Carrs index: 18 %

DPI Lactose_excipient inhalation_sieved_230 Mesh

Benefits

Dedicated production process
Tailor-made products with specific powder characteristics
Highest microbial quality including low endotoxins
Available in a broad spectrum of sieve cuts to meet your criteria

Areas of Application
With InhaLac^®, MEGGLE can offer customized milled and sieved fractions - specifically and efficiently prepared to meet your DPI formulation needs.

Typical particle size distribution (PSD) ofsomething new

InhaLac® 230

InhaLac^® 230